Page 1 of Clinical Trials for Shionogi [SPONSOR-COLLABORATORS], 67 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
A Phase 1 Study of S-3304 in Patients With Solid Tumors
Last Updated: June 23, 2005
Condition(s): Solid Tumors
2
Active, not recruiting
Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer
Last Updated: June 23, 2005
Condition(s): Non Small Cell Lung Cancer; Lung Cancer; Stage IIIA Non Small Cell Lung Cancer; Stage IIIB Non Small Cell Lung Cancer
3
Recruiting
A Study of S-297995 for the Treatment of Opioid-Induced Constipation in Subjects With Non-Malignant Chronic Pain Receiving Opioid Therapy
Last Updated: October 11, 2011
Condition(s): Opioid Induced Constipation
4
Completed
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet
Last Updated: September 13, 2011
Condition(s): Obesity
5
Completed
A Safety and Tolerability of PSD502 (a Topical Anesthetic) in the Treatment of Premature Ejaculation
Last Updated: September 13, 2011
Condition(s): Premature Ejaculation
6
Completed
A Safety and Tolerability Study of Administration of PSD502
Last Updated: September 13, 2011
Condition(s): Premature Ejaculation
7
Completed
A Phase Ib/IIa, Double-Blind, Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of S-777469 in Subjects With Atopic Dermatitis
Last Updated: September 13, 2011
Condition(s): Atopic Dermatitis
8
Completed
An Open-label Safety Study of S-888711
Last Updated: May 15, 2012
Condition(s): Immune Thrombocytopenia
9
Active, not recruiting
Efficacy & Safety of KAPVAY™ Extended-Release in Children & Adolescents With Attention Deficit Hyperactivity Disorder
Last Updated: March 1, 2012
Condition(s): Attention Deficit Hyperactivity Disorder
10
Completed
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects
Last Updated: September 13, 2011
Condition(s): Obesity
11
Completed
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Reduced Calorie Diet
Last Updated: September 13, 2011
Condition(s): Obesity
12
Completed
Study to Evaluate the Safety and Efficacy of S-297995 for the Treatment of Opioid-Induced Bowel Dysfunction in Subjects With Chronic Pain
Last Updated: September 13, 2011
Condition(s): Opioid Induced Bowel Dysfunction
13
Completed
A Clinical Study to Evaluate the Efficacy and Safety of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women
Last Updated: April 18, 2012
Condition(s): Atrophy; Vaginal Diseases
14
Terminated
A Study to Investigate the Efficacy and Safety of S-888711 Tablets Administered to Adult Subjects With Immune Thrombocytopenia (ITP)
Last Updated: September 13, 2011
Condition(s): Immune Thrombocytopenia (ITP)
15
Completed
Study to Assess Safety and Pharmacokinetics of Double-Blind S-707106 Alone and in Combination With Open-Label Metformin in Patients With Type 2 Diabetes Mellitus
Last Updated: September 13, 2011
Condition(s): Type 2 Diabetes Mellitus
16
Completed
Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus
Last Updated: April 23, 2012
Condition(s): Atrophy; Vaginal Diseases
17
Active, not recruiting
Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
Last Updated: April 18, 2012
Condition(s): Type 2 Diabetes Mellitus
18
Completed
Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus
Last Updated: April 24, 2012
Condition(s): Atrophy; Vaginal Diseases
19
Completed
Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity
Last Updated: April 18, 2012
Condition(s): Atrophy; Vaginal Diseases
20
Completed
Double-Blind, Multi-Center, Randomized Study to Assess the Efficacy and Safety of Velneperit (S-2367) and Orlistat Administered Individually or Combined With a Reduced Calorie Diet (RCD) in Obese Subjects
Last Updated: September 13, 2011
Condition(s): Obesity

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Shionogi

Page 1 of Clinical Trials for Shionogi [SPONSOR-COLLABORATORS], 67 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About